Low-Dose Versus Standard Dose of Bacillus Calmette-Guerin in the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis

Whether low-dose Bacillus Calmette-Guerin (BCG) treatment can reduce the side effects while maintaining efficacy for patients with nonmuscle invasive bladder cancer (NMIBC) is controversial. To investigate whether low-dose BCG treatment can reduce the side effects while maintaining efficacy for pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Shuxiong, Yu, Xiaowen, Ma, Chong, Zhang, Zhensheng, Song, Ruixiang, Chen, Xin, Sun, Yinghao, Xu, Chuanliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008490/
https://www.ncbi.nlm.nih.gov/pubmed/26656345
http://dx.doi.org/10.1097/MD.0000000000002176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008490/
https://www.ncbi.nlm.nih.gov/pubmed/26656345
http://dx.doi.org/10.1097/MD.0000000000002176

Ejemplares similares